These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ; Rossi AF; Courtney M; Gelb BD J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction. Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514 [TBL] [Abstract][Full Text] [Related]
6. The lymphocyte subpopulations in cyclosporine-treated human heart rejection. Weintraub D; Masek M; Billingham ME J Heart Transplant; 1985 Feb; 4(2):213-6. PubMed ID: 3916488 [TBL] [Abstract][Full Text] [Related]
14. The postsurgical heart. The pathology of cardiac transplantation. Billingham ME Am J Cardiovasc Pathol; 1988; 1(3):319-34. PubMed ID: 3061403 [TBL] [Abstract][Full Text] [Related]
16. Cardiac transplantation: role of endomyocardial biopsy and immunosuppressive agents. Eiswirth CC; Smart FW J La State Med Soc; 1993 May; 145(5):203-6. PubMed ID: 8340682 [TBL] [Abstract][Full Text] [Related]
17. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation. Hegewald MG; O'Connell JB; Renlund DG; Lee HR; Burton NA; Karwande SV; Jones KW; Lassetter JE; Bristow MR J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897 [TBL] [Abstract][Full Text] [Related]
18. Overview of tacrolimus-based immunosuppression after heart or lung transplantation. Reichenspurner H J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425 [TBL] [Abstract][Full Text] [Related]
19. Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation. De Maria R; Minoli L; Parolini M; Gavazzeni G; Gentile M; Grossi P; Livi U; Parisi F; Utili R J Heart Lung Transplant; 1996 Feb; 15(2):124-35. PubMed ID: 8672515 [TBL] [Abstract][Full Text] [Related]
20. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation. Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]